Cite

HARVARD Citation

    Iyer, R. et al. (2020). Multicenter phase 2 trial of nintedanib in advanced nonpancreatic neuroendocrine tumors. Cancer. 126 (16), pp. 3689-3697. [Online]. 
  
Back to record